Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18686822rdf:typepubmed:Citationlld:pubmed
pubmed-article:18686822lifeskim:mentionsumls-concept:C0340861lld:lifeskim
pubmed-article:18686822lifeskim:mentionsumls-concept:C0025080lld:lifeskim
pubmed-article:18686822lifeskim:mentionsumls-concept:C1414386lld:lifeskim
pubmed-article:18686822lifeskim:mentionsumls-concept:C0220905lld:lifeskim
pubmed-article:18686822lifeskim:mentionsumls-concept:C0015737lld:lifeskim
pubmed-article:18686822lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:18686822lifeskim:mentionsumls-concept:C1706778lld:lifeskim
pubmed-article:18686822lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:18686822pubmed:issue4lld:pubmed
pubmed-article:18686822pubmed:dateCreated2008-8-8lld:pubmed
pubmed-article:18686822pubmed:abstractTextIn an ever-growing environment of health expenditure, governments should consider methods to contain costs, for example: professional guidelines, appropriateness criteria, preauthorization mechanism and regulations. Certificate of Needs (CON), although controversial, was also considered as a tool to lower health costs by limiting the supply of health services. Therefore, expenditures on costly medical devices require the special attention of the Ministry of Health or regulatory authorities.lld:pubmed
pubmed-article:18686822pubmed:languageheblld:pubmed
pubmed-article:18686822pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18686822pubmed:citationSubsetIMlld:pubmed
pubmed-article:18686822pubmed:statusMEDLINElld:pubmed
pubmed-article:18686822pubmed:monthAprlld:pubmed
pubmed-article:18686822pubmed:issn0017-7768lld:pubmed
pubmed-article:18686822pubmed:authorpubmed-author:ShefferNadavNlld:pubmed
pubmed-article:18686822pubmed:authorpubmed-author:VakninSharona...lld:pubmed
pubmed-article:18686822pubmed:authorpubmed-author:TalOrnaOlld:pubmed
pubmed-article:18686822pubmed:issnTypePrintlld:pubmed
pubmed-article:18686822pubmed:volume147lld:pubmed
pubmed-article:18686822pubmed:ownerNLMlld:pubmed
pubmed-article:18686822pubmed:authorsCompleteYlld:pubmed
pubmed-article:18686822pubmed:pagination359-62, 372lld:pubmed
pubmed-article:18686822pubmed:meshHeadingpubmed-meshheading:18686822...lld:pubmed
pubmed-article:18686822pubmed:meshHeadingpubmed-meshheading:18686822...lld:pubmed
pubmed-article:18686822pubmed:meshHeadingpubmed-meshheading:18686822...lld:pubmed
pubmed-article:18686822pubmed:meshHeadingpubmed-meshheading:18686822...lld:pubmed
pubmed-article:18686822pubmed:meshHeadingpubmed-meshheading:18686822...lld:pubmed
pubmed-article:18686822pubmed:meshHeadingpubmed-meshheading:18686822...lld:pubmed
pubmed-article:18686822pubmed:year2008lld:pubmed
pubmed-article:18686822pubmed:articleTitle[Parameters for allocation of expensive medical devices (EMD) as a national regulatory mechanism].lld:pubmed
pubmed-article:18686822pubmed:affiliationMinistry of Health. orna.tal@moh.health.gov.illld:pubmed
pubmed-article:18686822pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18686822pubmed:publicationTypeEnglish Abstractlld:pubmed